Sivik Global Healthcare LLC Mirati Therapeutics, Inc. Transaction History

Sivik Global Healthcare LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$75.82 - $150.97 $751,982 - $1.5 Million	-9,918 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$132.01 - $190.29 $1.31 Million - $1.89 Million	9,918 New	9,918 $1.46 Million
Q3 2021 Nov 12, 2021	SELL	$132.13 - $177.45 $1.98 Million - $2.66 Million	-15,000 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$144.0 - $179.73 $720,000 - $898,650	5,000 Added 50.0%	15,000 $2.42 Million
Q1 2021 May 12, 2021	BUY	$158.92 - $221.61 $1.59 Million - $2.22 Million	10,000 New	10,000 $1.71 Million

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Sivik Global Healthcare LLC, based on Form 13F filings with the SEC.

Stay updated on Sivik Global Healthcare LLC with notifications on news.